🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PLAY and executed a BUY strategy, securing a +29.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$DYN

Dyne Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Jul 27, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.00%
MAX GAP RECORD0.00%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY0.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR DYN

AI REPORT Jun 10

Sector Rotation: Analyzing Where Institutional Money Flows

Analysis The financial markets are currently experiencing a dynamic period of sector rotation, driven by macroeconomic factors and…
VIEW REPORT_
AI REPORT Jun 10

Daily Champions: Identifying Top Stocks with High Confidence

Analysis While global markets have shown recent volatility, particularly driven by concerns over $AI developments in China and…
VIEW REPORT_
AI REPORT Jun 09

Sector Rotation: Where Institutional Money is Flowing in Today’s Market

Analysis Markets are currently experiencing significant sector rotation, driven by macroeconomic factors and shifting investor sentiment. Institutional investors…
VIEW REPORT_